scispace - formally typeset
Open AccessJournal ArticleDOI

Lytic cell death in metabolic liver disease.

Reads0
Chats0
TLDR
The role of hepatocyte necroptosis, pyroPTosis and ferroptosis in non-alcoholic fatty liver disease, alcohol-associated liver disease and other metabolic liver disorders, as well as potential of translation into human disease are focused on.
About
This article is published in Journal of Hepatology.The article was published on 2020-08-01 and is currently open access. It has received 92 citations till now. The article focuses on the topics: Liver cell & Necroptosis.

read more

Citations
More filters
Journal ArticleDOI

Ferroptosis in Liver Diseases: An Overview

TL;DR: The use of ferroptosis as a therapeutic approach against hepatocellular carcinoma, the most common form of primary liver cancer, and an overview of chemicals used as inducers and inhibitors are discussed.
Journal ArticleDOI

The multifaceted role of ferroptosis in liver disease

TL;DR: A review of the role of the liver in processing nutrients, the current understanding of iron metabolism, the characteristics of ferroptosis, and the mechanisms that regulate the progression of liver disease via this form of non-apoptotic cell death can be found in this paper .
Journal ArticleDOI

Oxidative stress and regulated cell death in Parkinson's disease.

TL;DR: In this paper, the main physiological characteristics responsible for the higher susceptibility of the nigrostriatal circuit to mitochondrial dysfunction and oxidative stress, as hinted by the acting mechanisms of the PD-causing neurotoxin 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP), were discussed.
Journal ArticleDOI

Cell Death in Liver Diseases: A Review.

TL;DR: In this paper, a review of cell death-related research in liver disease is presented, with a particular focus on cell death related research in humans and in rodent models of alcoholic liver disease, non-alcoholic fatty liver disease and steatohepatitis.
Journal ArticleDOI

FGF21: An Emerging Therapeutic Target for Non-Alcoholic Steatohepatitis and Related Metabolic Diseases.

TL;DR: Among this wave of therapeutic mechanisms targeting the underlying pathogenesis of NASH, the hormone fibroblast growth factor 21 (FGF21) holds considerable promise; it decreases liver fat and hepatocyte injury while suppressing inflammation and fibrosis across multiple preclinical studies.
References
More filters
Journal ArticleDOI

Ferroptosis: An Iron-Dependent Form of Nonapoptotic Cell Death

TL;DR: This paper identified the small molecule ferrostatin-1 as a potent inhibitor of ferroptosis in cancer cells and glutamate-induced cell death in organotypic rat brain slices, suggesting similarities between these two processes.
Journal ArticleDOI

Cleavage of GSDMD by inflammatory caspases determines pyroptotic cell death

TL;DR: Gasdermin D (Gsdmd) is identified by genome-wide clustered regularly interspaced palindromic repeat-Cas9 nuclease screens of caspase-11- and caspasing-1-mediated pyroptosis in mouse bone marrow macrophages to offer insight into inflammasome-mediated immunity/diseases and change the understanding of pyroPTosis and programmed necrosis.
Journal ArticleDOI

Regulation of Ferroptotic Cancer Cell Death by GPX4

TL;DR: Targeted metabolomic profiling and chemoproteomics revealed that GPX4 is an essential regulator of ferroptotic cancer cell death and sensitivity profiling in 177 cancer cell lines revealed that diffuse large B cell lymphomas and renal cell carcinomas are particularly susceptible to GPx4-regulated ferroPTosis.
Journal ArticleDOI

Molecular mechanisms of cell death: recommendations of the Nomenclature Committee on Cell Death 2018.

Lorenzo Galluzzi, +186 more
TL;DR: The Nomenclature Committee on Cell Death (NCCD) has formulated guidelines for the definition and interpretation of cell death from morphological, biochemical, and functional perspectives.
Related Papers (5)